During recent decades, the emergence of pathogenic fungi has posed an increasing public
health threat, particularly given the limited number of antifungal drugs available to treat …

Neutrophil extracellular traps (NETs), crucial in immune defense mechanisms, are
renowned for their propensity to expel decondensed chromatin embedded with inflammatory …

Aspergillosis is a fungal infection caused by various species of Aspergillus, most notably A.
fumigatus. This fungus causes a spectrum of diseases, including allergic bronchopulmonary …

Airway mucus dysfunction and impaired immunological defenses are hallmarks of several
lung diseases, including asthma, cystic fibrosis, and chronic obstructive pulmonary …

Aspergillus fumigatus causes aspergillosis and relies on asexual spores (conidia) for
initiating host infection. There is scarce information about A. fumigatus proteins involved in …

Chronic pulmonary aspergillosis (CPA) is a chronic progressive lung disease associated
with a poor prognosis and a 5-year mortality rate of approximately 40–50%. The disease is …

Aspergillus fumigatus and Fusarium solani infections have become severe health threat;
both pathogens are considered a priority due to the increasing emergence of antifungal …

Azole antifungals remain the “gold standard” therapy for invasive aspergillosis. The world-
wide emergence of isolates resistant to this drug class, however, developed into a steadily …

In the last decade, fungal respiratory diseases have been increasingly investigated for their
impact on the clinical course of people with cystic fibrosis (CF), with a particular focus on …

Advances in modern medical therapies for many previously intractable human diseases
have improved patient outcomes. However, successful disease treatment outcomes are …